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The electrochemical behavior of paclitaxel drug was studied at a glassy carbon electrode in
phosphate buffer solutions using cyclic and differential-pulse voltammetric techniques.
The oxidation process was shown to be irreversible over the pH range (3.0e10.4) and was
diffusion controlled. Effects of anodic peak potential (Ep), anodic peak current (Ipa), scan
rate, pH, heterogeneous rate constant (k0), etc have been discussed. A possible electro-
oxidation mechanism was proposed. An analytical method was developed for the deter-
mination of paclitaxel in phosphate buffer solution at pH ¼ 7.0 as a supporting electrolyte.
The anodic peak current varied linearly with paclitaxel concentration in the range
1.0  106 M to 1.0  105 M with a limit of detection (LOD) of 1.23  108 M and limit of
quantification (LOQ) of 4.10  108 M. The proposed method was successfully applied to the
determination of paclitaxel in pure and real samples.
ª 2013 Shenyang Pharmaceutical University. Production and hosting by Elsevier B.V. All
rights reserved.1. Introduction
Drug analysis is one of the important tools for drug quality
control. Therefore, the development of a simple, sensitive,
rapid, and reliable method for the determination of drugs is of
great importance. Paclitaxel (PAC), chemical structure as
given in Scheme 1, is a mitotic inhibitor used in cancer
chemotherapy. Paclitaxel is one of several cytoskeletal drugs
that target tubulin. Paclitaxel-treated cells have defects in
mitotic spindle assembly, chromosome segregation, and cell; fax: þ91 836 2747884.
(S.T. Nandibewoor).
g Pharmaceutical Univer
sevier
ang Pharmaceutical Univdivision. Unlike other tubulin-targeting drugs such as colchi-
cine that inhibit microtubule assembly, paclitaxel stabilizes
the microtubule polymer and protects it from disassembly.
Chromosomes are thus unable to achieve a metaphase spin-
dle configuration. This blocks progression of mitosis, and
prolonged activation of the mitotic checkpoint triggers
apoptosis or reversion to the G-phase of the cell cycle without
cell division [1,2].
Paclitaxel is approved for ovarian, breast and lung cancers
and Kaposi’s sarcoma [3]. It is recommended in NICE guidancesity
ersity. Production and hosting by Elsevier B.V. All rights reserved.
Scheme 1 e Chemical structure of paclitaxel.
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cancer in patients unsuitable for curative treatment, and in
first-line and second-line treatment of ovarian cancer and it
should be available for the treatment of advanced breast
cancer after the failure of anthracyclic chemotherapy.
Different methods have been reported for the determina-
tion of paclitaxel, including square wave voltammetry at
Cysteamine/DNA/SWNTs-Film modified Au electrode [4],
liquid chromatography with anodic amperometric detection
[5] and different HPLC methods for the determination of PAC
[6e10]. The main problems encountered in using such
methods are constructions of electrodes, time consuming
extraction and separation procedures.
The present study was to develop a simple, low-cost direct
current voltammetric method for determination of paclitaxel.
In the present work, we carried out the electrochemical
oxidation of paclitaxel at glassy carbon electrode. We
optimized all the experimental parameters for the determi-
nation of paclitaxel and developed an electro analytical
method for its determination. This method has the advan-
tages such as fast response, easy repair, renewal of the
paclitaxel, good reproducibility and low detection limit. The
proposed method was applied to the determination of pacli-
taxel in the injection and urine samples.Fig. 1 e Cyclic voltammograms at the glassy carbon
electrode in phosphate buffer solution (pH [ 7): (a) in the
presence bare pH [ 7; (b) in the presence of paclitaxel
(1.0 3 10L4 M) at the scan rate 0.05 VsL1.2. Materials and methods
2.1. Materials and reagents
Pure PAC in powdered form was obtained as a gift sample
from Reddy’s Laboratory, Hyderabad, India and was used
without further purification. A stock solution (1.0  104 M) of
PAC was prepared in methanol. Paclitaxel containing
injections marketed by NEON Lab. LTD. were purchased from
the local pharmacy. Phosphate buffer solutions (ionic
strength ¼ 0.2 M) were prepared according to the literature
method [11]. All other reagents used were of analytical grade.
All solutions were prepared in millipore water.
2.2. Apparatus
The electrochemical experiments were performed with CH
Instruments, USA, (Model 630D) Electrochemical Analyzer and
were carried out in a 10 mL single compartment three-
electrodes glass cell with a 3 mm diameter glassy carbonelectrode (GCE) as the working electrode (Part No. CHI104), a
platinum wire as counter electrode, and Ag/AgCl (3.0 M KCl)
electrode as reference electrode. All experiments were carried
out at an ambient temperature of 25  0.1 C. The pH
measurements were made with Elico pH meter model LI120.
The experimental conditions for differential pulse voltam-
metry (DPV) were: initial E: 0.8 V, final E: 1.4 V, sensitivity: 0.5 m
A/V, pulse amplitude: 4mV, samplewidth: 20ms, pulsewidth:
0.2 s, pulse period: 500 ms.2.3. Area of the electrode
The area of the electrode was obtained by the cyclic voltam-
metric method using 1.0 mM K3Fe(CN)6 as a probe at different
scan rates. For a reversible process, the following
RandleseSevcik formula was used [12].
Ipa ¼ 0:4463

F3=RT
1=2
n3=2A0D
1=2
o C0v
1=2 (1)
where Ipa refers to the anodic peak current, n is the number of
electrons transferred, A0 is the surface area of the electrode,
D0 is diffusion coefficient, v is the scan rate, and C0 is the
concentration, respectively, of K3Fe(CN)6. For 1.0 mM
K3Fe(CN)6 in 0.1 M KCl electrolyte, T ¼ 298 K, R ¼ 8.314 J/K.mol,
F ¼ 96,480 C/mol, n ¼ 1, D0 ¼ 7.6  106 cm2/s, then from the
slope of the plot of Ipa vs v1=2 the electroactive area
was calculated. In our experiment the slopewas 3.44 106 mA
(V/s)1/2 and the area of electrode was calculated to be
0.0464 cm2.2.4. Procedure
The GCE was polished using 0.3 micron Al2O3 before each
experiment. After polishing, the electrode was rinsed thor-
oughly with methanol and millipore water. After this me-
chanical treatment, the GCE was placed in pH ¼ 7 (0.2 M)
phosphate buffer solution and various voltammograms were
recorded.
Fig. 2 e Effect of accumulation time on the oxidation peak
current of 1.0 3 10L4 M PAC. Other conditions are same as
in Fig. 1.
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Taxeleon (paclitaxel) injection is a clear, colorless to slightly
yellow viscous solution. It is supplied as a nonaqueous solu-
tion intended for dilution with a suitable parenteral fluid prior
to intravenous infusion. Taxeleon is available in 100 mg in
16.67 mL. Accurately 1.42 mL of Taxeleon was pipetted and
was dissolved in 100 mL methanol to obtain 1.0 mM stock
solution. The mixture was allowed to stand for a few minutes
with intermittent sonication to ensure complete solubility of
the drug. An aliquot of this solution was transferred to a
voltammetric cell and analyzed under same conditions asFig. 3 e (A) Cyclic voltammograms for the oxidation of PAC at d
0.25/VsL1. (B) Dependence of oxidation peak current on the squa
peak current and logarithm of scan rate. (D) Dependence of oxiwere used to obtain the calibration graph. Voltammograms
were recorded as described for pure PAC.
To study the accuracy of the proposed method, and to
check the interference from excipients used in the dosage
forms, recovery experiments were carried out by the standard
additionmethod. This studywas performed by the addition of
known amounts of PAC to known concentration of the dosage.
The resulting mixture was analyzed as in pure PAC.3. Results and discussion
3.1. Cyclic voltammetric behavior of paclitaxel
The electrochemical behavior of PAC at glassy carbon elec-
trode was investigated using cyclic voltammetry (CV) at
physiological pH ¼ 7.0. The cyclic voltammograms obtained
for 1.0 104 M PAC solution at a scan rate of 50mV/s exhibit a
well-defined irreversible anodic peak at about 1.245 V at glassy
carbon electrode. The results are shown in Fig. 1. The
voltammograms corresponding to the first cycle was generally
recorded. However, no peak was observed in the reverse scan,
suggesting that the oxidation process is an irreversible one.
The oxidation product in turn did not show any re-oxidized or
reduced peak at the extended ranges of potential which
ensures that the oxidation product was not electroactive.3.2. Effect of accumulation parameters
The two parameters of accumulation step, i.e., accumulation
time and potential were examined. Open circuit accumulation
is widely used in electro analytical chemistry to accumulateifferent scan rates (1) 0.025 (2) 0.05 (3) 0.1 (4) 0.15 (5) 0.2 (6)
re root of scan rate. (C) Linear relation between logarithm of
dation peak potential on the logarithm of scan rate.
Fig. 4 e (A) Cyclic voltammograms of 1.0 3 10L4 PAC at
different pH: (a) 3.0 (b) 4.2 (c) 5.0 (d) 6.0 (e) 7.0 (f) 8.0 (g) 9.2 (h)
10.4 other conditions are same as in Fig. 1. (B). Influence of
pH on the potential of 1.03 10L4 PAC on GCE at scan rate of
50 mV/s in phosphate buffer. (C). Variation of current with
pH of 1.0 3 10L4 M PAC on GCE at scan rate of 50 mV/s in
phosphate buffer.
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ence of accumulation time ranging from 0 to 140 s on the
oxidation of PAC at GCE was as shown in Fig. 2. The current
increased gradually as accumulation time increased from 0 to
60 s. However, with further increasing, the accumulation time
beyond 60 s the peak current tends to be almost stable.
Therefore, the optimal accumulation time of 60 s was
employed in further experiments.
With the change of accumulation potential, the peak cur-
rent of PAC varied slightly. So, the accumulation potential had
no such effect on the peak current of PAC. Therefore the
accumulation was carried out at open-circuit conditions.
3.3. Effect of scan rate
Useful information involving electrochemical mechanism
generally can be acquired from the relationship between peak
current and scan rate. Therefore, the voltammetric behavior
of PAC at different scan rates was also studied using cyclic
voltammetry, (Fig. 3A). Scan rate studies were carried out to
assess whether the process on glassy carbon electrode was
under diffusion or adsorption controlled. The influence of the
square root of scan rate on the peak current showed a linear
relationship in the range of 0.025e0.25 mV/s (Fig. 3B) which is
of a typical diffusion controlled process [13], and the equation
can be expressed as
IpaðmAÞ ¼ 3:8178v1=2

V1=2s1=2
þ 0:3857; ðr ¼ 0:9874Þ (2)
A plot of logarithm of anodic peak current vs. logarithm of
scan rate gave a straight line with a slope of 0 0.44 (Fig. 3C),
which is close to the theoretical value of 0.5 for a purely
diffusion controlled process [14] which in turn further con-
firms that the process is diffusion controlled where the elec-
troactive species of PAC diffuses from the bulk solution to a
planar electrode surface. Data fit yields the equation,
log IpaðmAÞ ¼ 0:4404 log v

Vs1
þ 0:5813; ðr ¼ 0:9880Þ (3)
The Ep of the oxidation peak was also dependent on scan
rate. The peak potential shifted to more positive values on
increasing the scan rate, which confirms the irreversibility of
the oxidation process, and a linear relationship between peak
potential and logarithm of scan rate (Fig. 3D) can be expressed
by the following equation:
EpðVÞ ¼ 0:0391 log v

Vs1
þ 1:2969; ðr ¼ 0:9826Þ (4)
As for an irreversible electrode process, according to
Laviron [15], Ep is defined by the following equation.
Ep ¼ E00 þ

2:303RT
anF

log

RTk0
anF

þ

2:303RT
anF

log v (5)
where a is the transfer coefficient, k0 the standard heteroge-
neous rate constant of the reaction, n the number of electron
transferred, v the scan rate, and E0
0
is the formal redox
potential. Other symbols have their usual meanings. Thus
value of an can be easily calculated from the slope of Ep vs. log
v. In this system, the slope is 0.0391, taking T ¼ 298 K,
R ¼ 8.314 J/K mol, and F ¼ 96480 C/mol, the an was calculated
to be 1.512. According to Bard and Faulkner [16], a can be
given asa ¼ 47:7
Ep  Ep=2 mV (6)where Ep/2 is the potential where the current is at half the peak
value. So, from this we obtained the value of a to be 0.82.
Further, the number of electrons (n) transferred in the electro-
oxidation of PAC was calculated to be 1.84e2. The value of k0
can be determined from the intercept of the previous plot if
the value of E0
0
is known. The value of E0
0
in Eq. (5) can be
obtained from the intercept of Ep vs. v curve by extrapolating
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as 1.2969 and the k0 was calculated to be 2.14  103 s1.3.4. Influence of pH
The electrode reactionmight be affected by pH of themedium.
The electro-oxidation of 1.0 104 M PACwas studied over the
pH range of 3.0e10.4 in phosphate buffer solution by cyclic
voltammetry which is shown in Fig. 4A. The solution pH
influenced the peak current considerably. The pH dependence
of the peak potential and peak current obtained when cyclic
voltammetry was used is shown in Fig. 4B and C. With the
increase in pH of the solution, peak potential shifted to less
positive values, (Fig. 4B), and obeys the following equation:
EpðVÞ ¼ 1:6439 0:0565 pH; ðr ¼ 0:9960Þ (7)
The slope of this equation is found to be 56.5 mV/pH. This
closeness of the slope to the expected theoretical value [18] of
59mV/pH suggests that the number of electrons transferred is
equal to that of the hydrogen ions taking part in the electrode
reaction.
From the plot of Ipa vs. pH (Fig. 4C) it is clear that the in-
tensity was increased to a high value at pH ¼ 7.0, then the
peak intensity decreased. Because the best result with respectO
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Scheme 2 e Probable oxidatto sensitivity accompanied with sharper response was ob-
tained with pH ¼ 7.0, it was selected for further experiments.
3.5. Mechanism
In the proposedmethod, the electro-oxidation of PAC involves
two electron and two proton transfer process to form 7-oxo
peclitaxel. Literature survey reveals that C-7 hydroxyl group
of PAC is easily oxidized than C-20eOH to give 7-oxo paclitaxel
[19,20], (see Scheme 1). The probable mechanism is as shown
in Scheme 2.
Here the hydroxyl group (-OH) is attached to the carbon
atom (C-7) of the cyclohexane ring of the paclitaxel. During the
electrolysis when the first proton is removed, oxygen gets a
negative charge and anionic form of paclitaxel is formed. To
stabilize the anionic form of the paclitaxel the hydrogen atom
attached to the carbon (C-7) of the cyclohexane has undergone
further electro oxidation and stable product 7-oxo paclitaxel is
formed. This type of mechanism is also observed in previous
reports [21].
3.6. Calibration curve
In order to develop a voltammetrymethod for determining the
drug, we selected the differential-pulse voltammetric mode,O
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ion mechanism of PAC.
Table 1 e Characteristics of PAC calibration plot using
differential pulse voltammetry at glassy carbon electrode.
Linearity range 1.0  1061.0  105
Slope of the calibration plot (M) 6.617  105
Intercept 0.8957
Correlation coefficient (r) 0.9805
RSD of slope (%) 0.4094
RSD of intercept (%) 1.0675
Number of data points 8
LOD (M) 1.23  108
LOQ (M) 4.10  108
Repeatability of peak current (RSD %) 0.0176
Repeatability of peak potential (RSD %) 0.0013
Reproducibility of peak current (RSD %) 0.0370
Reproducibility of peak potential (RSD %) 0.0017
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concentration of PAC than those obtained by cyclic voltam-
metry. According to the obtained results, it was possible to
apply this technique to the quantitative analysis of PAC. The
phosphate buffer solution of pH ¼ 7.0 was selected as the
supporting electrolyte for the quantification of PAC as it gave
maximum peak current at pH ¼ 7.0. Differential pulse
voltammograms obtained with increasing amounts of PAC
showed that the peak current increased linearly with
increasing concentration, shown in Fig. 5A.
The precision of the method was evaluated by repeating
five experiments on the same day and in the same standard
condition (repeatability) and over 2 d from the different
standard solutions (reproducibility). For these studies
2  106 M paclitaxel standard solution were used. The results
were given as shown in Table 1.
Using the optimum conditions described previously, linear
calibration curves was obtained for PAC in the range of
1.0  106 to 1.0  105 M (Fig. 5B). The linear equation was
Ipa ¼ 661,700 C (105 M) þ 0.8957; (r ¼ 0.9943). Deviation from
linearity was observed for more concentrated solutions, due
to the adsorption of PAC or its oxidation product on the elec-
trode surface. Related statistical data of the calibration curves
were obtained from five different determinations and shown
in Table 1. The limit of detection (LOD) and quantificationFig. 5 e (A) Differential pulse voltammograms for
increasing concentration of PAC (mM): (a) 1.0 (b) 4.0 (c) 6.0 (d)
8.0 (e) 10.0 (f) 12.0 (g) 14.0 (h) 16.0, other conditions are
same as in Fig. 1. (B) Plot of current against the
concentration of PAC.(LOQ) were 1.23  108 M and 4.10  108 M, respectively. The
LOD and LOQ were calculated using the following equation:
LOD ¼ 3s=m; LOQ ¼ 10s=m (8)
where s is the standard deviation of the peak currents of the
blank (five runs), and m is the slope of the calibration curve
[22]. Sample solutions recorded after 48 h did not show any
appreciable change in the assay values. The detection limits
reported for different classical methods are tabulated in
Table 2. The present method was better as compared with
other reported classical methods [4,7,10].3.7. Effect of excipients
For the possible analytical application of the proposed
method, the effect of some common excipients used in
pharmaceutical preparations was examined. The tolerance
limit was defined as the maximum concentration of the
interfering substance that caused an error less than 5% for
determination of PAC. The effects of these excipients on the
voltammetric response was carried by analyzing sample
solutions containing a fixed amount of PAC (1.0  105 M)
spiked with various excess amount of each excipient under
the same experimental conditions. The experimental results
(Table 3) showed that hundred-fold excess of citric acid,
dextrose, glucose, gum acacia, lactose, starch, tartaric acid
and sucrose did not interfere with the voltammetric signal of
PAC. Thus, the procedures were able to assay PAC in the
presence of excipients, and hence it can be considered
specific.Table 2 e Comparison of detection limits for PAC to
different classical methods.
Methods LOD (mM) Reference
Cysteamine/DNA/SWNTs-Film
Modified au electrode
(cyclic voltammetry)
8.86 [4]
RP-HPLC method 0.0351 [7]
HPLC method 1.96 [10]
Glassy carbon electrode 0.0123 Present work
Table 3 e Inffuence of potential excipients on the
voltammetric response of 1.0 3 10L5 M PAC.
Excipients
(1.0 mM) þ drug (1.0  105)
Potential
observed (V)
Signal
change (%)
Only Paclitaxel 1.161 0
Citric acid þ PAC 1.170 þ0.77
Dextrose þ PAC 1.163 þ0.17
Glucose þ PAC 1.160 0.08
Gum acacia þ PAC 1.163 þ0.17
Lactose þ PAC 1.160 0.08
Sucrose þ PAC 1.158 0.25
Tartaric acid þ PAC 1.171 þ0.86
Starch þ PAC 1.158 0.25
Table 4 e Recovery test of PAC in Taxeleon injection.
Added
(M)
Found
(M)a
Recovery
(%)
Bias (%) S.D. 
R.S.D. (%)
3.0  106 2.980  106 99.33 0.67 0.023  0.789
5.0  106 5.020  106 100.4 0.40 0.079  1.562
8.0  106 7.890  106 98.62 1.37 0.071  0.911
1.0  105 0.998  105 99.8 0.20 0.019  1.940
3.0  105 3.102  105 103.4 3.40 0.0481  1.523
5.0  105 4.989  105 99.78 0.22 0.072  1.440
8.0  105 8.021  105 100.26 0.26 0.120  1.488
a Average of five determinations.
Table 6 e Response of peak current of 7 mM paclitaxel in
urine sample at different time intervals.
Time (min) Peak
current (mA)
Concentration (mM)
20 6.458 6.64
40 5.954 6.12
60 5.245 5.39
80 4.467 4.59
100 4.115 4.23
120 3.894 4.00
140 3.114 3.20
160 2.985 3.06
Elimination
rate constant
0.245 h1
Half life of drug 2.827 h
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In order to evaluate the applicability of the proposed method
in the pharmaceutical sample analysis, it was used to detect
PAC in “Taxeleon” injection (100 mg in 16.67 mL). The proce-
dure for the injection analysis was followed as described in
the procedural section. The results are in good agreement
with the content marked in the label. The detected content
was 100 mg per injection with 103.4% recovery.
The recovery test of PAC ranging from 3.0  106 to
8.0  105 M was performed using differential-pulse voltam-
metry. Recovery studies were carried out after the addition of
known amounts of the drug to various pre-analyzed formu-
lations of PAC. The results are listed in Table 4. The recoveries
in different samples were found to lie in the range from 98.6%
to 103.4% with R.S.D of 0.911%e1.523%.3.9. Detection of paclitaxel in urine samples
The developed differential voltammetric method for the PAC
determination was applied to urine samples. The recoveriesTable 5 e Determination of PAC in urine samples.
Sample Spiked (105 M) Founda (105 M)
1 1.0  106 1.01  106
2 4.0  106 4.00  106
3 6.0  106 6.02  106
4 8.0  106 7.92  106
5 10.0  106 9.77  106
a Average of five determination.from urine were measured by spiking drug free urine with
known amounts of PAC. A quantitative analysis can be carried
out by adding the standard solution of PAC into the detect
system of urine samples, and the peak linearly increased in
height. The calibration graph was used for the determination
of spiked PAC in urine samples. The detection results of four
urine samples obtained are listed in Table 5. The recovery
determined was in the range from 97.7% to 101.0% and the
RSD and SD values given in Table 5.
3.10. Pharmacokinetics study
Pharmacokinetics is the study of the time course of drug ab-
sorption, distribution, metabolism, and excretion. Clinical
pharmacokinetics is the application of pharmacokinetic
principles to the safe and effective therapeutic management
of drugs in an individual patient. Primary goals of clinical
pharmacokinetics include enhancing efficacy and decreasing
toxicity of a patient’s drug therapy. The development of strong
correlations between drug concentrations and their pharma-
cologic responses has enabled clinicians to apply pharmaco-
kinetic principles to actual patient situations. A drug’s effect is
often related to its concentration at the site of action, so it
would be useful to monitor this concentration. Receptor sites
of drugs are generally inaccessible to our observations or are
widely distributed in the body, and therefore direct mea-
surement of drug concentrations at these sites is not practi-
cable. We cannot directly sample drug concentration in this
tissue. However, drug concentration in the blood or plasma,
urine, saliva, and other easily sampled fluids can be
measured.
Response of peak current at different time interval for 7 mM
concentration of paclitaxel in urine sample is as shown inRecovery (%) Bias (%) S.D.  R.S.D (%)
101.0 1.00 0.019  0.014
100.0 0.20 0.017  0.012
100.3 0.34 0.0155  0.011
99.0 1.00 0.036  0.026
97.7 2.30 0.155  0.109
a s i a n j o u rn a l o f p h a rm a c e u t i c a l s c i e n c e s 9 ( 2 0 1 4 ) 4 2e4 9 49Table 6. From the plot of urine drug concentration vs. time
(supplementary Fig. S1) the pharmacokinetics data can be
calculated. Some of the pharmacokinetics data calculated are
listed in Table 6.4. Conclusion
The voltammetric oxidation of PAC at glassy carbon electrode
in phosphate buffer solution under physiological condition,
i.e., pH ¼ 7.0, has been investigated. Paclitaxel undergoes two
electron e two proton change and is a diffusion-controlled
process. A suitable oxidation mechanism was proposed. The
peak current was linear to PAC concentrations over a certain
range, under the selected conditions. This helps in voltam-
metric determination of selected analyte as low as
1.23 108 M and can be used successfully to assay the drug in
pharmaceutical dosage form as well as in spiked urine sam-
ples. High percentage recovery and study of excipients
showed that the method is free from the interferences of the
commonly used excipients and additives in the formulations
of drugs. In addition, the results obtained in the analysis of
PAC in spiked urine samples demonstrated the applicability of
the method in real sample clinical analysis. The proposed
method is suitable for quality control laboratories as well as
pharmacokinetic studies where economy and time are
essential.
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